Neuromodulation

Type: Keyphrase
Name: Neuromodulation
First reported Apr 19 2014 - Updated Apr 19 2014 - 1 reports

Neuromodulation Market (Spinal Cord Stimulation, Vagus Nerve...

This report estimates the Neuromodulation market for six major segments, namely, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcranial magnetic stimulation, and ... [Published PRWeb - Apr 19 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

St. Jude Medical receives FDA approval for pain management system

St. Jude Medical, Inc., a medical device company, has received FDA approval for its Protege IPG, indicated for management of chronic pain. Protege is the first and only neurostimulation system that allows spinal cord stimulation (SCS) technology upgrades ... [Published Individual.com - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 17 2014 - 1 reports

St. Jude Medical beats The Street, loses points anyway

by St. Jude Medical meets Wall Street's expectations for its 1st quarter of 2014 with moderate sales growth across its product lines, but shares take a downward turn in morning trading.Minnesota medtech titan St. Jude Medical  (NYSE: STJ ) lost a few ... [Published MassDevice - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 2 reports

St. Jude Medical's CEO Discusses Q1 2014 Results - Earnings Call Transcript

St. Jude Medical, Inc. ( STJ ) Q1 2014 Earnings Conference Call April 16, 2014 8:00 AM ETOperatorWelcome to the St. Jude Medical First Quarter 2014 Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President, and Chief Executive ... [Published Seeking Alpha - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

More on St. Jude Medical Q1: Net profit +11.7%; FY guidance soft

St. Jude Medical ( STJ ) Q1 net profit $249M vs $223M. Constant currency sales +4%. Sales breakdown: Cardiac Rhythm Management (CRM) +1% to $687M, with U.S. ICD sales +5%; Atrial Fibrillation (AF) +8% to $251M; Cardiovascular -1% to $326M; Neuromodulation ... [Published Seeking Alpha - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

Brain Monitoring Market (EEG/Magnetoencephalography (MEG)/Transcranial Doppler) worth $1.63 Billion - 2017

The "Brain Monitoring Market by Product [EEG/Magnetoencephalography (MEG)/Intracranial Pressure Monitor/Cerebral Oximeter/Transcranial Doppler] & Application [Sleep Disorders/Epilepsy/Traumatic Brain Injury/Brain Death] - Global Forecasts to 2017" analyzes ... [Published Individual.com - Apr 16 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Nerve Repair & Regeneration Market by Xenografts, Neuromodulation, External & Surgery - Global Trend & Forecast to 2018

DUBLIN, April. 11, 2014 /PRNewswire/ --Research and Markets(http://www.researchandmarkets.com/research/kjxvb2/nerve_repair_and) has announced the addition of the"Nerve Repair & Regeneration Market by Xenografts, Neuromodulation, External & Surgery - ... [Published PR Newswire: General Business - Apr 11 2014]
First reported Apr 05 2014 - Updated Apr 05 2014 - 1 reports

Renowned Neurosurgeon to Lecture on Neuromodulation for Treating Numerous Disorders

WRIGHT-PATTERSON AIR FORCE BASE, Ohio, April 4 -- The U.S. Air Force Aeronautical Systems Center issued the following press release:Dr. Ali Rezai, Director of the Ohio State University's Neuroscience Program and a world leader in deep brain stimulation ... [Published HighBeam Research - Apr 05 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

MRI INTERVENTIONS : Boston Scientific Neuromodulation Assigned Patent

By Targeted News ServiceALEXANDRIA, Va. , April 2 -- MRI Interventions , Memphis, Tenn. , and Boston Scientific Neuromodulation , Valencia, Calif. , have been assigned a patent (8,688,226) developed by five co-inventors for "MRI-safe high impedance lead ... [Published 4 Traders - Apr 02 2014]
First reported Mar 27 2014 - Updated Mar 28 2014 - 2 reports

Nerve Repair & Regeneration Market to Grow at a CAGR of 11.5% to 2018

RnRMarketResearch.comadds report “Nerve Repair & Regeneration Market by Xenografts (Conduits,Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External(Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] –Global ... [Published PitchEngine - Mar 28 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Boston Scientific Neuromodulation Assigned Patent for Efficient Charging Plurality

By Targeted News ServiceALEXANDRIA, Va., March 24 -- Boston Scientific Neuromodulation,Valencia, Calif., has been assigned a patent (8,676,318) developed bysix co-inventors for an "efficient external charger for charging aplurality of implantable medical ... [Published HispanicBusiness.com - Mar 25 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

Neuromodulation Market worth $6.8 Billion by 2017

The "Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017" ... [Published Individual.com - Mar 24 2014]

Quotes

...and president-elect of the International Neuromodulation Society, who was the first physician to implant a Protege system. "With its upgradeability, SCS patients can readily access newly approved stimulation methods, allowing the latest technology to be synced with their medical device. This will reduce additional surgeries and lower the cost of care."
...support the needs of our physicians, payors, and patients is a critical element in our overall business strategy," said Rob Kill, President & CEO. "Dan has the proven ability to accomplish these objectives and is a great addition to our team. His background and skills are an ideal complement to those of the strong management team we have brought on board during the past year to catapult Uroplasty into its next stage of growth."
...Magnetic resonance imaging ('MRI') or computerized tomography ( "CT') scans can provide a starting point for determining where the stimulating electrode should be positioned to provide the desired stimulus to the target neurons."
...on the company's financial results, St Jude MedicalJude Medical ChairmanChairman President and ChiefChief Executive Officer Daniel J Starks said, "St Jude Medical delivered a solid first quarter by meeting or exceeding our expectations in each of our technology platforms. These results reinforce our confidence that we are on track to accelerate sales growth as our product mix shifts to faster growing markets and as we continue to launch new products that improve patient outcomes, ensure the highest quality and lower the costs of treating expensive epidemic diseases."

More Content

All (92) | News (80) | Reports (0) | Blogs (6) | Audio/Video (0) | Fact Sheets (4) | Press Releases (2)
sort by: Date | Relevance
Neuromodulation Market (Spinal Cord Stimulation... [Published PRWeb - Apr 19 2014]
St. Jude Medical receives FDA approval for pain... [Published Individual.com - Apr 17 2014]
Uroplasty Names Daniel P. Merz As Vice Presiden... [Published TickerTech.com - Apr 17 2014]
Patent Issued for Systems and Methods for Makin... [Published 4 Traders - Apr 17 2014]
St. Jude Medical's CEO Discusses Q1 2014 Result... [Published Seeking Alpha - Apr 16 2014]
St. Jude Medical beats The Street, loses points... [Published MassDevice - Apr 16 2014]
St. Jude Medical's net sales increase 2% in fir... [Published News-Medical.Net - Apr 16 2014]
More on St. Jude Medical Q1: Net profit +11.7%;... [Published Seeking Alpha - Apr 16 2014]
Brain Monitoring Market (EEG/Magnetoencephalogr... [Published Individual.com - Apr 16 2014]
ST JUDE MEDICAL : Updates on Approval of Proteg... [Published 4 Traders - Apr 15 2014]
Children's Hospitals And Clinics Of Minnesota A... [Published TheStreet.com - Apr 14 2014]
Mice Model Market (Microinjection, Embryonic St... [Published Digital Journal - Apr 14 2014]
New Boston Sci registry to evaluate Vercise DBS... [Published Medical Device Daily - Apr 12 2014]
First Patient Enrolled in Clinical Registry Ass... [Published Medical Design Technology - Apr 11 2014]
Nerve Regeneration Market worth $7.8 billion by... [Published PitchEngine - Apr 11 2014]
Nerve Repair & Regeneration Market by Xenograft... [Published PR Newswire: General Business - Apr 11 2014]
Boston Scientific enrolls first patient in clin... [Published Medical Devices Business Review - Apr 11 2014]
Autologous Cell Therapy Market worth $2.2 Billi... [Published Individual.com - Apr 09 2014]
ST JUDE MEDICAL : Secures FDA Approval for Its ... [Published 4 Traders - Apr 09 2014]
St Jude Medical : Reports Approval of Protege I... [Published 4 Traders - Apr 09 2014]
St. Jude's Upgradeable Neurostimulator Gains FD... [Published QMED - Apr 07 2014]
Renowned Neurosurgeon to Lecture on Neuromodula... [Published HighBeam Research - Apr 05 2014]
FDA approves first upgradeable neurostimulation... [Published Medical Device Daily - Apr 05 2014]
Researchers Submit Patent Application, "Anchori... [Published HighBeam Research - Apr 04 2014]
Nevro Corp Strengthens Leadership Team With The... [Published FierceBiotech - Apr 04 2014]
World's First and Only Upgradeable Spinal Cord ... [Published Investor's Business Daily - Apr 04 2014]
World's First and Only Upgradeable Spinal Cord ... [Published Nasdaq - Apr 04 2014]
Study shows new SCS lead is safe for MRI use [Published Orthopedics Today - Apr 02 2014]
Patent Application Titled "System and Method fo... [Published HighBeam Research - Apr 02 2014]
MRI INTERVENTIONS : Boston Scientific Neuromodu... [Published 4 Traders - Apr 02 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Nerve Repair & Regeneration Market by Xenograft... [Published PR Newswire: General Business - Apr 11 2014]
DUBLIN, April. 11, 2014 /PRNewswire/ --Research and Markets(http://www.researchandmarkets.com/research/kjxvb2/nerve_repair_and) has announced the addition of the"Nerve Repair & Regeneration Market by Xenografts, Neuromodulation, External & Surgery - ...
Pixium hires new CEO and director [Published PE Hub Blog - Mar 26 2014]
Pixium has appointed Khalid Ishaque as CEO and director. Previously, Ishaque worked at Boston Scientific where he most recently served as general manager of its neuromodulation international business. Based in Paris, Pixium is a maker of vision restoration ...
Arch Therapeutics Co-Founder Rutledge Ellis-Beh... [Published Marketwire - Breaking News Releases - Mar 26 2014]
Discusses AC5(TM) at the Brainstorming Neuromodulation Workshop and 4th Annual Meeting of American Society of Nanomedicine ...
The Daily Startup: Peter Thiel Backs New Zealan... [Published WSJ.com: Venture Capital Dispatch - Mar 25 2014]
In today’s VentureWire ( subscription required ): Art by Mike Lucas Cash registers powered by traditional point-of-sale software have been clunky to use, and it’s another category of software that’s moving to the cloud–with help from a young New Zealand-based ...
Axonics Modulation Technologies nabs $32.6 mln ... [Published PE Hub Blog - Mar 25 2014]
Axonics Modulation Technologies has closed $32.6 million in Series A financing. Edmond de Rothschild Investment Partners led the round with participation from NeoMed Management, Legend Capital and various private investors. In conjunction with ...
1 2

Press Releases

sort by: Date | Relevance
Soterix Medical Inc., Rogue Resolutions Ltd., a... [Published PR Newswire - Dec 02 2013]
Neuromodulation Market - Forecasts to 2017 [Published GlobeNewswire: Licensing Agreements News - Oct 23 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.